Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-13 07:31 am Purchase | 2023-11-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 97,319,355 13.880% | 1,758,195 (+1.84%) | Filing History |
| 2023-11-08 07:06 am Purchase | 2023-11-06 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 95,561,160 13.630% | 2,188,575 (+2.34%) | Filing History |
| 2023-11-06 07:30 am Purchase | 2023-11-03 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 93,372,585 13.320% | 1,081,380 (+1.17%) | Filing History |
| 2023-11-02 07:30 am Purchase | 2023-10-31 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,291,205 13.250% | 92,130 (+0.10%) | Filing History |
| 2023-10-30 6:02 pm Purchase | 2023-10-27 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 92,199,075 13.150% | 2,168,475 (+2.41%) | Filing History |
| 2023-07-25 4:13 pm Purchase | 2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 26,713,503 19.000% | 14,963,503 (+127.35%) | Filing History |
| 2023-06-30 08:29 am Purchase | 2023-06-28 | 13D | TherapeuticsMD, Inc. TXMD | Rubric Capital Management LP | 2,069,716 19.570% | 347,763 (+20.20%) | Filing History |
| 2023-06-16 08:00 am Purchase | 2023-06-14 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 90,030,600 14.410% | 6,250,000 (+7.46%) | Filing History |
| 2023-05-02 5:07 pm Sale | 2023-04-30 | 13G | Chimerix, Inc. CMRX | Rubric Capital Management LP | 4,779,020 5.390% | -20,980 (-0.44%) | Filing History |
| 2023-02-22 4:24 pm Unchanged | 2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 11,750,000 9.900% | 0 (Unchanged) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Digimarc Corporation DMRC | Rubric Capital Management LP | 1,214,593 6.060% | 1,214,593 (New Position) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | BGC Partners, Inc. BGCP | Rubric Capital Management LP | 18,250,000 5.640% | 18,250,000 (New Position) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Amryt Pharma plc AMYT | Rubric Capital Management LP | 18,000,000 5.610% | 277,660 (+1.57%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Rubric Capital Management LP | 3,333,628 9.930% | 727,128 (+27.90%) | Filing History |
| 2023-02-10 4:00 pm Sale | 2022-12-31 | 13G | EverQuote, Inc. EVER | Rubric Capital Management LP | 1,246,622 4.800% | -31,740 (-2.48%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Rubric Capital Management LP | 1,835,387 5.970% | 1,835,387 (New Position) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Xperi Inc. XPER | Rubric Capital Management LP | 3,843,744 9.150% | 3,843,744 (New Position) | Filing History |
| 2023-02-10 4:00 pm Sale | 2022-12-31 | 13G | Whole Earth Brands, Inc. FREE | Rubric Capital Management LP | 998,363 2.380% | -2,101,637 (-67.79%) | Filing History |
| 2023-02-10 4:00 pm Sale | 2022-12-31 | 13G | Golar LNG Limited GLNG | Rubric Capital Management LP | 6,352,756 5.910% | -447,431 (-6.58%) | Filing History |
| 2023-02-10 4:00 pm Sale | 2022-12-31 | 13G | Ferroglobe PLC GSM | Rubric Capital Management LP | 3,232,762 1.730% | -10,415,949 (-76.31%) | Filing History |